The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: A meta-analysis

Gene

Volumn 527, Issue 1, 2013, Pages 95-101

  Wang, Bin ^a   Zhu, Ji Min ^b   Fan, Yin Guang ^a   Feng, Chen Chen ^a   Chen, Gui Mei ^a   Chen, Hong ^a   Pan, Hai Feng ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

IL1; Meta analysis; Polymorphism; Systemic lupus erythematosus

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

AFRICAN AMERICAN; ALLELE; ARTICLE; ASIAN; EUROPEAN AMERICAN; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACR; CI; CONFIDENCE INTERVAL; DEGREE OF FREEDOM; DF; ET AL.; ET ALIA; HARDY-WEINBERG EQUILIBRIUM; HWE; IL1; IL1RA; INTERLEUKIN 1; INTERLEUKIN-1 RECEPTOR ANTAGONIST; META-ANALYSIS; ODDS RATIO; OR; POLYMORPHISM; SLE; SYSTEMIC LUPUS ERYTHEMATOSUS; THE AMERICAN COLLEGE OF RHEUMATOLOGY; VERSUS; VS.;

CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; LUPUS ERYTHEMATOSUS, SYSTEMIC; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84881262233     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.05.059     Document Type: Article

References (39)

1. Alarcon-Segovia D., Alarcon-Riquelme M.E. Etiopathogenesis of systemic lupus erythematosus: itineraries of three troikas. Systemic Lupus Erythematosus 2004, 93-107. Elsevier, SanDiego. 4th ed. R.G. Lahita (Ed.).
2. Alheim K., Bartfai T. The interleukin-1 system: receptors, ligands and ICE in the brain and their involvement in the fever response. Ann. N. Y. Acad. Sci. 1998, 840:51-58.
3. Al-Tahhan M.A., Etewa R.L., El Behery M.M. Association between circulating interleukin-1 beta (IL-1beta) levels and IL-1beta C-511T polymorphism with cervical cancer risk in Egyptian women. Mol. Cell. Biochem. 2011, 353:159-165.
4. Andersen L.S., Petersen J., Svenson M., Bendtzen K. Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE. Autoimmunity 1999, 30:235-242.
5. Aotsuka S., et al. Production of intracellular and extracellular interleukin-1 alpha and interleukin-1 beta by peripheral blood monocytes from patients with connective tissue disease. Ann. Rheum. Dis. 1991, 50:27-31.
6. Arend W. Interleukin 1 receptor antagonist. J. Clin. Invest. 1991, 88:1445-1451.
7. Attia J., Thakkinstian A., D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J. Clin. Epidemiol. 2003, 56:297-303.
8. Boswell J.M., Yui M.A., Endres S., Burt D.W., Kelly V.E. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J. Immunol. 1988, 141:3050-3054.
9. Bresnihan B., Cunnane G. Interleukin-1 receptor antagonist. Rheum. Dis. Clin. North Am. 1998, 24:615-628.
10. Camargo J.F., Correa P.A., Castiblanco J., Anaya J.M. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun. 2004, 5(8):609-614.
11. Cochran W.G. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
12. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-178.
13. Dinarello C. The interleukin-1 family: 10years of discovery. FASEB J. 1994, 8:1314-1325.
14. Egger M., Davey Smith G., Schneider M., Minder C. Bias in metaanalysis detected by a simple, graphical test. Br. Med. J. 1997, 315:629-634.
15. Fishman D., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
16. Harley J.B., Kelly J.A., Kaufman K.M. Unraveling the genetics of systemic lupus erythematosus. Springer Semin. Immunopathol. 2006, 28:119-130.
17. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a metaanalysis. Stat. Med. 2002, 21:1539-1558.
18. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. Br. Med. J. 2003, 327:557-560.
19. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
20. Huang C.M., Wu M.C., Wu J.Y., Tsai F.J. Lack of association of interleukin-1beta gene polymorphisms in Chinese patients with systemic lupus erythematosus. Rheumatol. Int. 2002, 21(5):173-175.
21. Jandle R.C., George J.L., Silberstein D.S., Eaton R.B., Schur P.H. The effect of adherent cell-derived factors on immunoglobulin and anti-DNA synthesis in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1987, 42:344-359.
22. Ketlinskii S.A., Alekseeva T.G., Perumov N.D., Simbirtsev A.S. The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis. Ter. Arkh. 1993, 65:51-54.
23. Kobayashi T., et al. The combined genotypes of stimulatory and inhibitory Fc gamma receptors associated with systemic lupus erythematosus and periodontitis in Japanese adults. J. Periodontol. 2007, 78(3):467-474.
24. Lee Y.H., et al. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. Arthritis Rheum. 2005, 52:3966-3974.
25. Lee Y.H., Lee H.S., Choi S.J., Ji J.D., Song G.G. The association between interleukin-6 polymorphisms and systemic lupus erythematosus: a meta-analysis. Lupus 2012, 21(1):60-67.
26. Liu L., Zeng F., Wang K., Huang J., Xin L., Zhu P.Q. Meta-analysis of the association between VEGF-634G>C and risk of malignancy based on 23 case-control studies. J. Cancer Res. Clin. Oncol. 2011, 137:1027-1036.
27. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-728.
28. Muraki Y., et al. Polymorphisms of IL-1 beta gene in Japanese patients with Sjögren's syndrome and systemic lupus erythematosus. J. Rheumatol. 2004, 31(4):720-725.
29. Parks C.G., et al. Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann. Rheum. Dis. 2004, 63(1):91-94.
30. Ramos P.S., Brown E.E., Kimberly R.P., Langefeld C.D. Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin. Nephrol. 2010, 30:164-176.
31. Reiner A.P., et al. Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. Arterioscler. Thromb. Vasc. Biol. 2008, 2008(28):1407-1412.
32. Rus V., et al. Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin. Immunol. 2002, 102:283-290.
33. Sánchez E., et al. Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus. BMC Med. Genet. 2006, 7:48.
34. Stroup D.F., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
35. Sung I.H., et al. IL-23R polymorphisms in patients with ankylosing spondylitis in Korea. J. Rheumatol. 2009, 36:1003-1005.
36. Tan E.M., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25:1271-1277.
37. Tsai L.J., Hsiao S.H., Tsai J.J., Lin C.Y., Tsai L.M., Lan J.L. Higher genetic susceptibility to inflammation in mild disease activity of systemic lupus erythematosus. Rheumatol. Int. 2009, 29(9):1001-1011.
38. Wang X., et al. Single-nucleotide polymorphisms and expression of IL23R in Chinese ankylosing spondylitis patients. Rheumatol. Int. 2010, 30(7):955-959.
39. Wang B., et al. Association of the -1082G/A polymorphism in the interleukin-10 gene with systemic lupus erythematosus: a meta-analysis. Gene 2013, 519(2):209-216.